CRBU
Price
$0.79
Change
-$0.07 (-8.14%)
Updated
Apr 3 closing price
Capitalization
73.02M
39 days until earnings call
XOMA
Price
$19.24
Change
-$0.57 (-2.88%)
Updated
Apr 4, 10:30 AM (EDT)
Capitalization
237.3M
39 days until earnings call
Ad is loading...

CRBU vs XOMA

Header iconCRBU vs XOMA Comparison
Open Charts CRBU vs XOMABanner chart's image
Caribou Biosciences
Price$0.79
Change-$0.07 (-8.14%)
Volume$953.8K
Capitalization73.02M
XOMA Royalty
Price$19.24
Change-$0.57 (-2.88%)
VolumeN/A
Capitalization237.3M
CRBU vs XOMA Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. XOMA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and XOMA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CRBU: $0.79 vs. XOMA: $19.81)
Brand notoriety: CRBU and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 83% vs. XOMA: 147%
Market capitalization -- CRBU: $73.02M vs. XOMA: $237.3M
CRBU [@Biotechnology] is valued at $73.02M. XOMA’s [@Biotechnology] market capitalization is $237.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and XOMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while XOMA’s TA Score has 5 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 4 bearish.
  • XOMA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, XOMA is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -20.60% price change this week, while XOMA (@Biotechnology) price change was -5.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

CRBU is expected to report earnings on May 13, 2025.

XOMA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($237M) has a higher market cap than CRBU($73M). XOMA YTD gains are higher at: -24.619 vs. CRBU (-50.629). XOMA has higher annual earnings (EBITDA): -18.71M vs. CRBU (-162.69M). CRBU has more cash in the bank: 210M vs. XOMA (143M). CRBU has less debt than XOMA: CRBU (26.5M) vs XOMA (119M). CRBU (9.99M) and XOMA (9.71M) have equivalent revenues.
CRBUXOMACRBU / XOMA
Capitalization73M237M31%
EBITDA-162.69M-18.71M869%
Gain YTD-50.629-24.619206%
P/E RatioN/AN/A-
Revenue9.99M9.71M103%
Total Cash210M143M147%
Total Debt26.5M119M22%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUXOMA
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.58N/A
N/A
ESSA Pharma
DNN1.24-0.06
-4.62%
Denison Mines Corp
FRHC127.61-9.95
-7.23%
Freedom Holding Corp
AVGO154.01-18.08
-10.51%
Broadcom Inc.
ATLC46.97-5.91
-11.18%
Atlanticus Holdings Corp

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with FATE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-8.83%
FATE - CRBU
55%
Loosely correlated
-11.69%
CCCC - CRBU
55%
Loosely correlated
-9.54%
CRSP - CRBU
52%
Loosely correlated
-4.47%
ALLO - CRBU
52%
Loosely correlated
-4.17%
NKTX - CRBU
51%
Loosely correlated
-10.73%
More